The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Metabolic Tumor Volume Predicts for Recurrence and Death in Head-and-Neck Cancer
Open accessAbstract
Purpose To evaluate the prognostic value of metabolic tumor volume measured on 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) imaging and other clinical factors in patients treated for locally advanced head and neck cancer at a single institution. Materials/Methods From March 2003 to August 2007, 85 patients received PET/CT-guided chemoradiotherapy for HNC. Metabolically active tumor regions were delineated on pretreatment PET scans semi-automatically using custom software. We evaluated the relationship of FDG-PET maximum standardized uptake value (SUV) and total metabolic tumor volume (MTV) with disease-free survival (DFS) and overall survival (OS). Results Mean follow-up for surviving patients was 20.4 months. The estimated 2-year locoregional control, DFS, and OS for the group were 88.0%, 69.5% and 78.4%, respectively. The median time to first failure was 9.8 months among the 16 patients with relapse. An increase in MTV of 17.4 mL (difference between the 75th and 25th percentiles) was significantly associated with an increased hazard of first event (recurrence or death) (1.9-fold, p<0.001), even after controlling for Karnofsky performance status (KPS) (1.8-fold, p=0.001), and of death (2.1-fold, p<0.001). We did not find a significant relationship of maximum SUV, stage, or other clinical factors with DFS or OS. Conclusion Metabolic tumor volume is an adverse prognostic factor for disease recurrence and death in HNC. MTV retained significance after controlling for KPS, the only other significant adverse prognostic factor found in this cohort. MTV is a direct measure of tumor burden and is a potentially valuable tool for risk stratification and guiding treatment in future studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885
Cited by
Milano, M. T., Katz, A. W., Zhang, H., & Okunieff, P. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.08.036 · Cited by 439
Zhang, H., Wroblewski, K., Liao, S., Kampalath, R., Penney, B. C., Zhang, Y., & Pu, Y. (2013) · Academic Radiology · doi:10.1016/j.acra.2012.07.002 · Cited by 290
Liao, S., Penney, B. C., Wroblewski, K., Zhang, H., Simon, C. A., Kampalath, R., Shih, M.-C., Shimada, N., Chen, S., Salgia, R., et al. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1934-6 · Cited by 287
Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer
Chung, H. H., Kim, J. W., Han, K. H., Eo, J. S., Kang, K. W., Park, N.-H., Song, Y.-S., Chung, J.-K., & Kang, S.-B. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.11.002 · Cited by 126
Lee, P., Bazan, J. G., Lavori, P. W., Weerasuriya, D. K., Quon, A., Le, Q.-T., Wakelee, H. A., Graves, E. E., & Loo, B. W. (2012) · Clinical Lung Cancer · doi:10.1016/j.cllc.2011.05.001 · Cited by 92
Self-citation
Metadata
- Authors
- La, T. H., Filion, E. J., Turnbull, B. B., Chu, J. N., Lee, P., Nguyen, K., Maxim, P., Quon, A., Graves, E. E., Loo, B. W., & Le, Q.-T.
- Venue
- International Journal of Radiation Oncology*Biology*Physics
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 74
- Issue
- 5
- Pages
- 1335-1341
- ISSN
- 0360-3016 (ISSN-L)
- OpenAlex
- W2159705543
- Cited by
- 201
- References
- 1
- FWCI
- 18.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metabolic Tumor Volume Predicts for Recurrence and Death in Head-and-Neck Cancer. https://app.cochat.ai/papers/10.1016/j.ijrobp.2008.10.060
- The paper
- La, T. H., Filion, E. J., Turnbull, B. B., Chu, J. N., Lee, P., Nguyen, K., Maxim, P., Quon, A., Graves, E. E., Loo, B. W., & Le, Q.-T. (2009). Metabolic Tumor Volume Predicts for Recurrence and Death in Head-and-Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2008.10.060
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.